JPS637550B2 - - Google Patents

Info

Publication number
JPS637550B2
JPS637550B2 JP56116323A JP11632381A JPS637550B2 JP S637550 B2 JPS637550 B2 JP S637550B2 JP 56116323 A JP56116323 A JP 56116323A JP 11632381 A JP11632381 A JP 11632381A JP S637550 B2 JPS637550 B2 JP S637550B2
Authority
JP
Japan
Prior art keywords
dianhydro
group
desoxy
iditol
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56116323A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5764696A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Willmar Schwabe GmbH and Co KG
Original Assignee
Dr Willmar Schwabe GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe GmbH and Co KG filed Critical Dr Willmar Schwabe GmbH and Co KG
Publication of JPS5764696A publication Critical patent/JPS5764696A/ja
Publication of JPS637550B2 publication Critical patent/JPS637550B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
JP56116323A 1980-07-25 1981-07-24 Aminodesoxy-1,4;3,6-dianhydrohexitol derivative and acid addition salt thereof Granted JPS5764696A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803028288 DE3028288A1 (de) 1980-07-25 1980-07-25 Gegebenenfalls n-substituierte aminodesoxy-1.4;3.6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und deren verwendung

Publications (2)

Publication Number Publication Date
JPS5764696A JPS5764696A (en) 1982-04-19
JPS637550B2 true JPS637550B2 (2) 1988-02-17

Family

ID=6108128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56116323A Granted JPS5764696A (en) 1980-07-25 1981-07-24 Aminodesoxy-1,4;3,6-dianhydrohexitol derivative and acid addition salt thereof

Country Status (7)

Country Link
US (2) US4413122A (2)
EP (1) EP0044932B1 (2)
JP (1) JPS5764696A (2)
AT (1) ATE12499T1 (2)
CA (1) CA1248096A (2)
DE (1) DE3028288A1 (2)
ES (1) ES8403902A1 (2)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3028272A1 (de) * 1980-07-25 1982-02-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Durch purinbasen substituierte alkylamino-desoxy-1.4;3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung
DE3421072A1 (de) * 1984-06-06 1985-12-12 Heinrich Mack Nachf., 7918 Illertissen 1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA2014520C (en) * 1989-04-17 1996-07-16 Fumio Suzuki Hexitol derivatives
AU683287B2 (en) 1993-07-23 1997-11-06 Merrell Pharmaceuticals Inc. Novel 9-N-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
US6994310B2 (en) * 2003-04-24 2006-02-07 Ranco Incorporated Of Delaware Stepper motor driven valve for thermal management and associated method of use
DE102009000592A1 (de) 2009-02-04 2010-08-05 Evonik Degussa Gmbh Verfahren zur Herstellung von Aminogruppen tragenden, multizyklischen Ringsystemen
KR102638391B1 (ko) 2023-05-30 2024-02-20 삼화페인트공업주식회사 다이알칸설포닐 아이소소바이드 화합물의 제조 방법, 리튬이차전지용 전해액 첨가제, 리튬이차전지용 전해액 및 리튬이차전지

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545635A1 (de) * 1965-10-16 1969-08-07 Boehringer Mannheim Gmbh Verfahren zur Herstellung von Adenosin-Derivaten
AU465217B2 (en) * 1971-04-29 1975-09-18 American Home Products Corporation Mononitrte esters of 1,4:3, 6-dianhydro-d-glucitol
US3886186A (en) * 1971-04-29 1975-05-27 American Home Prod Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol
DE3028273A1 (de) * 1980-07-25 1982-02-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Durch purinbasen substituierte 1.4;3.6-dianhydro-hexit-nitrate

Also Published As

Publication number Publication date
US4535158A (en) 1985-08-13
US4413122A (en) 1983-11-01
EP0044932A1 (de) 1982-02-03
DE3028288C2 (2) 1991-10-10
DE3028288A1 (de) 1982-02-25
ES503997A0 (es) 1984-04-16
ES8403902A1 (es) 1984-04-16
ATE12499T1 (de) 1985-04-15
EP0044932B1 (de) 1985-04-03
CA1248096A (en) 1989-01-03
JPS5764696A (en) 1982-04-19

Similar Documents

Publication Publication Date Title
DK175372B1 (da) 1,3-dioxolanderivater
FI58920C (fi) Foerfarande foer framstaellning av blodkaerlsutvidgande (omega-1)-oxoalkyl-dialkylxantiner
AU695032B2 (en) Purine and guanine compounds as inhibitors of PNP
US7687500B2 (en) Substituted oxetanes, method of making, and method of use thereof
US5514798A (en) Method and cyclic carbonates for nucleotide analogues
JP2856773B2 (ja) 化合物の新規な製造方法
CA2094270C (en) Xanthine derivatives
CA1244411A (en) Aminodesoxy-1.4;3.6-dianhydrohexitol nitrates, processes for their preparation and pharmaceutical composition
JP2025507915A (ja) ジアシルグリセロールキナーゼ（ＤＧＫ）α阻害剤及びその使用
JPH0247476B2 (2)
EP3174892A1 (en) Synthesis of phosphoramidates
JPS637550B2 (2)
EP0704445B1 (en) Preparation of N-9 substituted guanine compounds
KR20010023890A (ko) 항비루스제로서의 퓨린 아시클로뉴클레오시드류
CA1186687A (en) Alkylaminodesoxy-1.4;3.6-dianhydrohexitol nitrates substituted by purine bases, processes for their preparation and pharmaceutical compositions
WO2000006573A1 (en) Antiviral alkyl substituted purine derivatives and their preparation
HU196207B (en) Process for preparing 9-/2-hydroxy-ethoxy/-methyl-guanine
NO169652B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive guaninderivater
DE69025084T2 (de) Hexitolderivate
DE3606634A1 (de) Isohexid-nucleoside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US3029239A (en) Basic substituted 1-and 7-alkylxanthines or salts thereof
JPH06247942A (ja) ピペラジン誘導体
EP0564006A2 (en) Process for preparing purine derivatives and novel purine derivatives
US20170313735A1 (en) Improved Fluorination Process
RU2733731C1 (ru) Способ получения промежуточных продуктов для синтеза каланолидов и их аналогов